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β-pancreatic islet cells generate action potentials (AP) spontaneously or in response to different stimuli. This is 
orchestrated by the activity of diverse voltage-gated ion channels in the plasma membrane. Therefore, metabolic signals that 
modify the functional expression of these channels may alter β-cells excitability and in consequence the secretion of insulin. 
In particular, two hormones that regulate the voluntary food intake, Ghrelin and Leptin, may affect glucose serum 
concentrations by altering plasma insulin release. In this work, we use the insulin-producing RIN-M5f cell line to study the 
effects of the chronic treatment with Ghrelin or Leptin on the functional expression of voltage-gated Na+ and Ca2+ channels. 
Cells were kept in culture and then subjected to patch-clamp electrophysiology. Our results show that chronic incubation 
with Ghrelin or Leptin (10 nM, 72 h) increased the frequency of the spontaneous APs and the macroscopic current density 
through Na+ and Ca2+ channels. The analysis of the components of the Ca2+ currents showed that Ghrelin and Leptin 
differentially increased low- and high-threshold channels without causing apparent changes in current kinetics. The study of 
the electrophysiological mechanisms in insulin-secreting cells associated with the effects of Ghrelin and Leptin may shed 
light on the molecular processes involved in the endocrine/metabolic balance. 
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Insulin secretion by β-pancreatic cells is essential in 
the control of blood glucose levels. Insulin is secreted 
by the β-cells of the pancreatic islets of Langerhans in 
response to elevation of the intracellular Ca2+ 
concentration ([Ca2+]i). This is produced by an influx 
of extracellular Ca2+ via voltage-dependent Ca2+ 
channels, whose activity, in turn, is regulated by the 
β-cell membrane potential. This means that electrical 
activity is critically important for insulin release1. 
Glucose, the main physiological regulator of insulin 
secretion, enters the β-cells through the GLUT2 
(Slc2a2) membrane transporter. After glycolysis, 
pyruvate enters cycling routes in the mitochondria to 
produce NADH+ and FADH+, which transfer 
electrons to the respiratory chain producing ATP and 
increasing the ATP/ADP ratio in the cytosol2. An 
important aspect of ATP production it that leads, via 
KATP channel closure and initiating action potential 
(AP) firing, and causing the opening of voltage-gated 
Ca2+ (CaV) channels that allow the entry of Ca2+ into 
the cells1,3,4. The increase in [Ca2+]i favors the 
mobilization of insulin granules towards the 
membrane and the consequent secretion of insulin1,4. 
Pancreatic β-cells express three types of CaV 
channels, and those of the L-type appear to be 
involved in the initial phase of insulin secretion5-11. 
Insulin acts on hepatocytes, adipocytes and striated 
myocytes to promote glucose uptake, but also has an 
anabolic activity that promotes the synthesis of 
glycogen, lipids, and proteins12. When the production 
or release of insulin to the circulatory system 
decreases or ceases, the individuals develop  
diabetes mellitus.  
The control of insulin secretion occurs mainly by 
glucose, but there are other molecules involved in the 
energy balance that also contribute to its regulation 
including hormone and growth factors, among 
others13. Of particular interest for this work are 
Ghrelin and Leptin, two hormones involved in the 









through an increase in the secretion of neuropeptide Y 
(NPY) and the protein related to the agouti gene14-17, 
and its secretion is stimulated in response to a 
negative energy balance, while its release and 
synthesis decrease under conditions of positive  
energy balance18. Under pathological conditions, the 
circulating levels of Ghrelin are reduced, in obesity, 
but they increase in malnutrition, cachexia and 
anorexia nervosa19. Leptin, on the other hand, is 
expressed mainly in white adipose tissue and acts as 
an indicator of the body energy reserves. Leptin also 
contributes to the regulation of the energy balance, the 
appetite and the control of body weight, as well as in 
the metabolism of lipids and carbohydrates20,21. Leptin 
has been proven to increase with increasing adiposity 
in humans and rodents22. Given that, the presence of 
leptin reduces food intake and body weight, elevated 
levels of leptin in obese persons is viewed as leptin 
resistance23-25.  
Previous studies of our group have shown that 
chronic treatment (≥48 h) with Ghrelin or Leptin may 
affect current density by increasing the number of 
NaV and CaV channels in the plasma membrane in 
endocrine cells. Hence, Ghrelin or its synthetic analog 
GHRP-6 increases whole-cell inward current density, 
enhances AP firing frequency and facilitates GH 
secretion from clonal and pituitary somatotropes26-29. 
In addition, we have reported that Leptin enhances the 
functional expression of NaV and CaV channels and 
modulates the AP firing pattern and the secretory 
properties of isolated gonadotropes30. Therefore, the 
main aim of the present report was to assess the 
potential effects of Ghrelin or Leptin chronic 
treatment on the properties of the macroscopic 
currents through NaV and CaV channels in the  
RIN-m5f insulin-secreting cells. The investigation of 
the mechanisms underlying the actions of Ghrelin and 
Leptin on insulin-producing cells may be fundamental 
for a better understanding the physiological processes 
that are affected in endocrine/metabolic imbalance 
conditions as is the case of diabetes mellitus. 
 
Materials and Methods 
 
Cell culture 
The rat (Rattus norvegicus) insulinoma cell line 
RIN-m5f (ATTC CRL-11605) from pancreas/islet of 
Langerhans31, was kept in culture in RPMI 1640 
medium supplemented with 10% fetal bovine serum 
(Bio Wets), L-glutamine and 1% penicillin-streptomycin 
under an atmosphere of 95% air and 5% CO2, at 37°C. 
The RIN-m5F cell line is a clone derived from the 
RIN-m rat islet cell line, produce and secrete insulin. 
Once confluence was reached, cells were harvested by 
treatment with trypsin-EDTA and re-seeded in 35 mm 
diameter Petri dishes for treatment with 10 nM 
Ghrelin27-29 or 10 nM Leptin30 (American Peptide Co); 
and Ghrelin 10 nM plus 1 μM of D-Lys3 GHRP-628 
(ENZO Life Sciences) an antagonist of GHS-R1a, the 
Ghrelin receptor.  
 
Electrophysiology 
The RIN-m5F cells were subjected to 
electrophysiological recording using the patch-clamp 
technique in the whole-cell configuration in its two 
modalities, current and voltage clamp, as previously 
described26-29. In current clamp modality, control and 
treated cells were recording without current injection 
and two types of responses were observed: (i) Silent, 
a cell without spontaneous electrical activity,  
(ii) Spontaneous Action Potential (SAP), an active 
cell with spontaneous electrical activity firing. 
Recordings were carried out at room temperature 
(~22°C) and the micropipettes were made of 
borosilicate glass tubing. Recording micropipettes had 
resistances of ~4 MΩ once filled with the internal 
recording solution. Voltage and current-clamp 
recordings were performed using an Axopatch 200B 
amplifier (Molecular Devices). After reaching the 
whole-cell configuration, currents were evoked by 
depolarizing pulses of variable amplitude and 
duration from a holding potential (Vh) of −80 mV 
applied at intervals of 1-10 s using a Digidata 1440A 
interface (Molecular Devices) controlled by a 
computer. Current signals were acquired at 10-100 μs 
and filtered at 5 kHz. Data was stored on the 
computer and analyzed using pCLAMP v10.1 and 
Sigma Plot v11.0 software. The leakage and 
capacitative currents were digitally subtracted offline. 
Series resistance was not compensated, but cells were 
excluded from further analysis if values changed by 
>20% during the course of the recording. Membrane 
capacitance (Cm) and Membrane resistance (Rm) was 
determined as described previously26-29 and Cm was 
used to normalize currents. To block INa, 1 µM TTX 
was added to the external solution, to block ICa2+  
0.5 mM CdCl2 was added to the external solution and 
to block IK+ 100 mM CsCl was added to the internal 
solution. The composition of the recording solutions 
is given in (Table 1). The osmolarity was adjusted to 
300 and 290 mOsmol/L for the bath (external) and 
pipette (internal) recording solutions, respectively. 




Control and treated cells were rinsed with peptide-free 
culture medium and maintained in this medium for 
60 min before electrophysiological recording. 
 
Insulin secretion 
The amount of insulin secreted by the RIN-m5F 
cells was determined by the enzyme-linked 
immunosorbent assay (ELISA) using the rat insulin 
ELISA kit (Alpco) according to the manufacturer’s 
recommendations. Cells were seeded in 24-well 
culture dishes at a density of 2x104 cells per well and 
incubated for 72 h with a 10 nM Ghrelin or Leptin. 
Cells were then preincubated with Krebs-Ringer 
buffer containing (in mM) 115 NaCl, 5 KCl, 1 MgCl2, 
2.5 mM CaCl2, 24 NaHCO3, 25 HEPES, and 0.1% 
BSA for 5 min at 37°C. The preincubation buffer was 
removed and replaced with Krebs-Ringer buffer 
containing a high KCl concentration (40 mM) for  
10 min at 37°C. 
 
Data analysis 
Data were analyzed and plotted by the combined 
use of pCLAMP software (see above) and SigmaPlot 
software (SPSS, Chicago, IL). The One-way analysis 
of variance (ANOVA) was used to determine 
statistically significant differences between the means 
of the groups, followed by the Turkey multiple 
comparison tests for possible pairwise differences. A 
P value <0.05 was considered to be statistically 
significant. Data are presented as means ± SE unless 
otherwise specified. Curve fits were made using the 
nonlinear, least-squares fitting procedure included in 
the Sigma Plot program. For analyzing activation 
kinetics of Ica2+, tail current decay was fitted according 
to the method of Matteson and Armstrong32. In brief, 
the first step consisted in fitting a least-squares 
exponential to the slow component of the tail current, 
and extrapolate this exponential to the beginning of 
the step. The fitted slow exponential was then 
subtracted out, and the remaining current was fitted 
with a least-squares exponential. To minimize 
possible errors, the initial amplitude of the tail current 
was taken as the amplitude of the fitted exponential 
measured 100 µs after the onset of repolarization. 
Conductance at each test potential was estimated by 
measuring tail current amplitude. Conductance-
Voltage (G–V) curves for activation were fitted with a 
Boltzmann equation of the form: G = Gmax/(1 + exp 
[(Vm - V1/2)/k]-1), where Gmax is maximum 
conductance, Vm is the test potential, V1/2 is the 
potential for half-maximal activation of Gmax and k is 
a slope factor. For analyzing activation kinetics of 
INa+, conductance was calculated from I/V curves 
values and normalized to its maximal value, 
conductance in treated cells was normalized to their 
corresponding control. For analyzing voltage 
dependence of steady-state inactivation of INa+, 
currents were recorded after conditioning pulses of 1s 
duration, applied from a Vh of −100 mV in 10 mV 
steps, followed by a 20 ms test pulse to −10 mV. The 
normalized data were plotted against the conditioning 
potentials. Data points in the G-V and inactivation 
curves were fitted with Boltzmann equations. The 
number of analyzed cells is given in parentheses.  
 
Results 
Initially, we examined the SAP firing pattern in 
RIN-m5F cells under control conditions and after 
chronic treatment (72 h) with Ghrelin or the Leptin 
(10 nM). Figure 1 shows that 69% of the control 
cells fire SAPs and that this was increased to 78% in 
the cells treated with the two hormones without 
significant differences (P> 0.05) (Fig. 1A). In most 
control cells the firing frequency was relatively low 
(1 Hz), while in treated cells this frequency was 
significantly (P< 0.05) increased to >3 Hz (Fig. 1A & 
1B, Table 1). Figure 1C shows that the peak of the 
APs in the control cells was reached rapidly (5 ms) 
and had amplitudes of 57 mV. In contrast, in the 
cells treated with Ghrelin and Leptin, the electrical 
activity was characterized by SAPs significantly 
faster and larger (3.4 ms and 68 mV; Table 2). 
Table 1 — Recording solutions 
Solution NaCl KCl CaCl2 TEA-Cl BaCl2 CsCl MgCl2 ATP/GTP CdCl2 TTX EGTA Hepes Glu pH 
Totale 145 5 5         10 5 7.3 (NaOH) 
Nae 150  2      0.5   10 5 7.3 (NaOH) 
Bae 133   10 10     0.001  10 5 7.3 (NaOH) 
Totali 30 100 1    2 2/0.05   10 10 5 7.3 (KOH) 
Nai 30  1   100 2 2/0.05   10 10 5 7.3 (CsOH) 
Bai 30  1   100 2 2/0.05   10 10 5 7.3 (CsOH) 
Note: Totale, Nae, Bae, bath solutions. Totali, Nai, Bai, pipette solutions. Units are in mM 
 




We next investigated whether there were 
differences in the total ionic currents after the Leptin 
and Ghrelin treatments that could explain the changes 
in the SAP firing patterns in the RIN-m5F cells. 
Figure 1D upper panel shows a family of total 
currents in RIN-m5f cells under control conditions 
and treated with Leptin or Ghrelin where it is 
appreciated that the peptides increase the inward 
currents and outward currents. In lower right panel the  
current-voltage (I-V) relationships obtained using the 
whole-cell configuration of the patch-clamp technique 
in the absence and presence of the two hormones.  
In response to voltage steps of 20 ms ranging from 
−80 to +50 mV (in 10 mV step increments) from a Vh 
of −80 mV, an inward current of rapid activation and 
inactivation was observed, which was followed by a 
 
 
Fig. 1 — Chronic treatment with Leptin or Ghrelin affects the electrical activity of RIN-m5F cells. (A) Percentage of Silent and 
electrically active cells (left). The SAPs were recorded using the patch-clamp technique in modality Current Clamp without current 
injection (gap free) and the number of recorded cells is indicated in parentheses. The panel on the right shows the comparison of the SAPs 
firing frequency as in A; (B) Patterns of SAPs firing under control conditions and after hormone treatment (n=15-18); (C) Individual 
SAPs displayed on an expanded time scale recorded in control (black solid line) and treated with Leptin (red solid line) or Ghrelin (blue 
solid line). The analysis of the SAPs properties is shown in Table 2; and (D) Representative whole-cell patch clamp currents recorded in 
response to 300 ms command steps ranging −80 to +50 mV from a Vh of −80 mV in control and treated cells. I-V plots for total currents 
recorded from control (n=15) and treated with Leptin (n=17) or Ghrelin (n=16) 
 
Table 2 — Membrane and action potential properties 
 Control (10) Leptin (12) Ghrelin (11) 
Membrane resistance (G) 1.98 ± 0.41a 1.19 ± 0.19b 1.31 ± 0.33b 
Membrane capacitance (pF) 17.01 ± 0.91a 18.06 ± 0.83a 17.02 ± 1.03a 
Resting membrane potential (mV) 37.2 ± 3.4a 44.8 ± 2.53b 45.6 ± 2.41b 
Peak amplitude (mV) 56.6 ± 0.4a 68.2 ± 0.4b 68.7± 0.5b 
Time to peak (ms) 5.2 ± 0.05a 3.4 ± 0.06b 3.4 ± 0.06b 
Half-amplitude (mV) 28.3 ± 0.2a 34.2 ± 0.2b 34.4 ± 0.2b 
Maximum rise slope (mV/ms) 5.1 ± 0.1a 8.2 ± 0.1b 8.3 ± 0.1b 
Maximum decay slope (mV/ms) 3.9 ± 0.1a 5.4 ± 0.1b 5.5 ± 0.1b 
Area (mV.ms) 558 ± 12a 460 ± 11b 466 ± 12b 
Instantaneous frequency (Hz) 1.0 ± 0.2a 2.8 ± 0.1b 2.8 ± 0.1b 
a, bDifferent literals between column of the same row are statistically significant (P < 0.05) 
Note: Values expressed as mean ± SEM 




non-inactivating outward component. The inward 
current was activated at membrane potentials (Vm) 
>−40 mV, while the outward component became 
evident at Vm >−10 mV. Based on the recording 
conditions (Table 1) and the kinetic analysis, it was 
inferred that the inward current corresponded  
to the activity of NaV and CaV channels, while  
the outward current corresponded to the activation  
of KV channels. 
Interestingly, the chronic treatment of the RIN-m5F 
cells with Leptin or Ghrelin increased significantly 
(P< 0.05) the amplitude of the inward currents, 
without apparent effects on the outward current (not 
analyzed), in comparison with the controls (Fig. 1D). 
These results suggested that the hormone treatment 
may produce an increase in the functional expression 
of NaV and CaV channels and might represent a 
plausible mechanism by which the hormones may 
alter SAPs firing. Although it has been shown that the 
effects of the acute treatment with Ghrelin on insulin 
release depend on [Ca2+]i transient elevations with the 
participation of the L-type channels28, to our 
knowledge, the increase in the functional expression 
of NaV and CaV channels in response to the chronic 
treatment has not been reported previously. 
Given that Leptin and Ghrelin increased the 
frequency of SAPs firing in the RIN-m5F cells, we 
next investigated whether the functional expression of 
NaV channels was affected by the hormone treatment. 
As shown in (Fig. 2A), the application of voltage 
steps in the range of -80 to +50 mV (in 5-mV step 
increments) from a Vh of -80 mV resulted in inward 
currents that reached the peak in 1 ms and that 
decayed also rapidly. After chronic treatment with 
Leptin or Ghrelin (10 nM, 72 h), the maximum  
Na+ current (INa) amplitude increased significantly  
(30-42%) from a control value of 275 ± 46 to 392 ± 
47 and 471 ± 60 pA, respectively (Fig. 2B). To 
eliminate the size of the cell as a variable source, the 
current value was divided by its respective 
capacitance value to obtain the current density 
(pA/pF), Leptin and Ghrelin increase significantly 
(P< 0.05) the current density (Fig. 2C). 
After that, we investigated whether the effect of the 
Leptin and Ghrelin involved changes in the voltage 
dependence of the macroscopic INa. To this end, the 
 
 
Fig. 2 — Chronic treatment with Leptin and Ghrelin increases the functional expression of NaV channels in RIN-m5F cells. (A) 
Representative INa trace currents evoked by depolarizing pulses ranging −80 to +50 mV from a Vh of −80 mV in cells kept in culture for 72 h
in the absence or presence of the hormones; (B) Comparison of the average I-V plots obtained in control (n=10) and cells treated with Ghrelin
(n=10) or Leptin (n=12), as indicated; (C) Bar chart summarizing the effects of Ghrelin and Leptin on current densities, INa+ were recorded 
at −10 mV from a Vh of −80; (D) Comparison of the normalized G-V plots estimated from the cells shown in B; data was fitted with
Boltzmann equations; and (E) Comparison of normalized INa+ steady-state inactivation plots in control and hormone-treated cells 




currents in the three experimental conditions were 
normalized and the respective conductance-voltage 
(G-V) plots were generated. The results of this 
analysis showed that the position of the curves in the 
voltage axis was similar, suggesting that the 
activation of the channels was not altered by the 
hormone treatment (Fig. 2D). Here, it is worth 
recalling that alterations in Gmax in the absence of 
changes in the voltage dependence or kinetics of the 
macroscopic currents are likely related to differences 
in the number of channels at the plasma membrane. In 
these experiments, the parameters describing the 
inactivation curves for the control condition were 
similar to the corresponding values obtained from 
cells treated with Leptin or Ghrelin (Fig. 2E). 
After the analysis of the INa, a series of experiments 
were conducted to compare the CaV channel 
functional expression in the control condition and 
after chronic incubation with Leptin or Ghrelin. 
Figure 3A shows representative traces of the Ba2+ 
current (IBa) through CaV channels recorded in the 
control condition and in treated cells either with 
Ghrelin or its receptor antagonist [D-Lys3]-GHRP-6. 
The use of [D-Lys3]-GHRP-6 was to corroborate 
whether the effect showed by treatment of Ghrelin 
was to GHS-R1a activation and were used in 
combination with Ghrelin in a 1 µM concentration by 
the same exposition time. The analysis of the 
waveform and the I-V plots suggested the presence of 
two subtypes of channels (LVA and HVA) in the cell 
membrane of the RIN-m5F cells. Notably, in the 
presence of the Ghrelin receptor antagonist, the 
increase of IBa density was prevented (Fig. 3B). 
We next explored whether the treatment with 
Ghrelin could differentially affect the two components 
of IBa in the RIN-m5F cells. Hence, we measured the 
amplitude of the remaining current at the end of a  
300 ms step to isolate the non-inactivating component 
(HVA channels). Subsequently, this component was 
subtracted from the total current to thereby obtaining 
the rapidly inactivating component (LVA channels). 
Figure 3C shows that the density of the Ipeak (at 0 mV) 
 
 
Fig. 3 — Ghrelin chronic treatment increases the functional expression of CaV channels in RIN-m5F cells. (A) Representative IBa traces in 
response to voltage steps of 300 ms ranging from −80 to +50 mV from a Vh of −80 mV in control and Ghrelin-treated cells; 
(B) Comparison of the I-V plots obtained from current (Ipeak, Isustained and Ipeak-Isustained) recordings cells treated with the hormone as in A;
(C) Comparison of the effect of the Ghrelin treatment on the total (Ipeak), HVA (Isustained) and LVA (Ipeak-Isustained) current densities obtained 
by applying depolarizing pulses to 0 mV from a Vh of −80 mV; (D) Representative IBa traces recorded in response to voltage steps of
10 ms ranging −80 to +40 mV from a Vh of −80 mV in control and Ghrelin-treated cells, in which the closing (deactivation) of the
channels is observed immediately after returning Vm to the Vh level (tail currents); and (E) Comparison of the position of the normalized
current plots in the voltage axis for the HVA and LVA currents (fast and slow components, respectively) estimated from the analysis of 
the tail currents. The data points were fitted with Boltzmann equations 




increased significantly (P< 0.05) from 12.1 ±  
1.2 pA/pF in the control cells to 16.6 ± 1.9 pA/pF  
in the cells exposed to Ghrelin. Likewise, the 
inactivating component was increased from 6.5 ±  
0.6 pA/pF in the control cells to -7.9 ± 0.9 pA/pF in 
the cells incubated chronically with Ghrelin and  
the sustained component did not show changes 
significantly. We also corroborated the presence of 
the two components of IBa by analyzing tail currents. 
The traces in (Fig. 3D) confirm our observation that 
IBa is larger in the RIN-m5F cells incubated with the 
hormone in comparison to the controls. On the other 
hand, when the fast and slow components of the tail 
currents are normalized and plotted as a function of 
voltage, the position of the curves in the voltage axis 
was similar, corroborating that Ghrelin increases the 
amplitude of the currents without affecting the 
channel voltage dependence of activation (Fig. 3E). 
The same voltage protocols were used then to 
investigate the effect of the chronic incubation with 
Leptin on CaV channel functional expression in the 
RIN-m5F cells. Figure 4A shows representative IBa 
traces recorded in control and Leptin-treated cells, 
where the presence of the two subtypes of the 
channels, LVA and HVA, was corroborated. As can 
be seen, the amplitude of the currents in cells treated 
with Leptin was significantly greater than those of the 
control cells at potentials ≥0 mV, suggesting a 
preferential effect of the hormone on the HVA 
channels (Fig. 4B). Consistent with this, the density of 
 
 
Fig. 4 — Chronic Leptin treatment affects the functional expression of CaV channels in RIN-m5F cells. (A) Representative IBa traces recorded 
in response to voltage steps of 300 ms ranging from −80 to +40 mV from a Vh of −80 mV in control and Leptin-treated cells. Lower panel, 
comparison of the effect of the Leptin treatment on the total (Ipeak), HVA (Isustained) and LVA (Ipeak-Isustained) current densities obtained by 
applying depolarizing pulses to 0 mV from a Vh of −80 mV; (B) Comparison of the I-V plots obtained from current (Ipeak, Isustained and Ipeak-
Isustained) recordings cells treated with the hormone as in A; (C) Representative IBa traces recorded in response to voltage steps of 10 ms
ranging −80 to +50 mV from a Vh of −80 mV in control and Leptin-treated cells, in which the closing (deactivation) of the channels is
observed immediately after returning Vm to the Vh level (tail currents); (D) Time course of the effect of Leptin and Ghrelin on IBa recorded at 
0 mV from a Vh of −80 mV as a function of time in culture in the presence of the hormones. The asterisks indicate significant differences
(P<0.05); and (E) Basal and high-K+ induced insulin secretion in RIN-m5F cells after treatment with Leptin or Ghrelin. Cells were treated 48
h with the hormones and subsequently incubated with buffer containing 5 (low-K+) or 40 mM (high-K+) KCl. The insulin content in the 
supernatants was determined by ELISA. Data represent the mean ± SE of triplicates obtained in three independent experiments 




the sustained IBa component (at 10 mV) was 
significantly increased from 6.45 ± 0.59 pA/pF  
in the control cells to 10.79 ± 0.98 pA/pF in the 
Leptin-exposed cells. As observed from the results in 
the I-V plot, the inactivating component showed a 
decrease significantly in cells incubated with Leptin 
from −6.23 ± 0.49 pA/pF in the control cells to  
4.02 ± 0.48 pA/pF in the Leptin-exposed cells.  
(Fig. 4A). We also corroborated the presence of the 
two components of IBa by analyzing tail currents as 
showed by Ghrelin. The traces in (Fig. 4C) confirm 
our observation that IBa is larger in the RIN-m5F cells 
incubated with Leptin comparison to the controls. The 
fast and slow components of the tail currents were 
normalized and plotted as a function of voltage, the 
position of the curves in the voltage axis was similar, 
corroborating that Leptin increases the amplitude of the 
sustained current component (Isustained) without affecting 
the channel voltage dependence of activation (Fig. 4C).  
The time course of IBa stimulation by Leptin, as 
well as by Ghrelin, was also investigated. Figure 4D 
shows that IBa amplitude, normalized with respect to 
the controls, was slightly increased within the first  
24 h of treatment which became more evident 
gradually as a function of time, being statistically 
different and reaching a maximum at 48 h.  
Last, we quantified the release of insulin from  
RIN-m5F cells kept in culture under control conditions 
and in presence of the hormones (10 nM) for 48 h. 
Figure 4E shows that Leptin -induced an increase in 
insulin secretion both basal (low K+) and stimulated by 
the influx of Ca2+ evoked by membrane depolarization 
with high K+ (40 mM for 30 min). Interestingly, insulin 
secretion was not affected in cells treated with Ghrelin. 
In order to represent the effect of Ghrelin or Leptin 
on electrical and secretory activity of RIN-m5F cells, 
it was proposed to develop a model that showed the 
effect (Fig. 5.) 
 
Discussion 
The cellular and molecular mechanisms by  
which Ghrelin and Leptin may affect the function of 
insulin-producing cells are largely unknown. Given 
that the secretion of insulin is associated with 
elevations in [Ca2+]i that are mediated by Ca2+ entry 
through CaV channels activated by cell membrane 
depolarization during SAPs firing, in the present 
report we investigated whether these hormones 
 
 
Fig. 5 — Action model of the effect of Ghrelin and Leptin on the electrical and secretory activity of -pancreatic cells (RIN-m5F) 
 




modify the ionic currents that give rise to the SAPs in 
the insulin-producing RIN-m5F cells. 
In the first instance, we examined the SAP firing 
pattern in RIN-m5F cells under control conditions and 
after chronic treatment with Ghrelin and Leptin. At 
non-stimulatory glucose concentrations, it has been 
reported that the mouse and human β-cell is 
hyperpolarized and electrically silent. The membrane 
potential can be as negative as −80 mV for mouse and 
−70mV for human, which is close to that predicted  
for a pure K+ conductance. Increasing glucose to  
5 mM depolarizes the β-cell to about −60 mV. In 
previous reports, electrical activity is not elicited  
until the glucose concentration exceeds 6 mM,  
which depolarises the membrane to between −60 and 
−50 mV1. In the present report, a concentration of  
5 mM of glucose was used in the electrophysiological 
recording solutions (Table 1), which could result in 
modifications in the membrane potential of the cells 
in the different conditions. Control cells showed a 
resting membrane potential more depolarized than 
cells treated with the energy balance hormones, 
probably due to an increase in the potassium current 
observed in the total current data by treated cells. 
The control cells fire SAPs and the frequency were 
increased in the cells treated. Rorsman and Ashcroft1 
have reported that in mouse and human β-cells have a 
highly distinctive glucose-dependent pattern of 
electrical activity. At glucose concentrations between 
6-20 mM, this consists of short-lived bursts of action 
potentials, superimposed on a depolarized plateau and 
separated by repolarized electrically silent intervals, 
in human are shorter (~2 s) and more frequent than 
those of mouse. The action potentials observed in 
RIN-m5F did not show bursts of action potentials as 
shown by mouse and human β-cells, even though the 
record was maintained for 20 sec. Potential membrane 
values observed in the present report under control 
conditions are similar to observed in rat islets33, in 
other reports indicate that rat β-cells generate 
oscillatory electrical activity very similar to that of 
mouse β-cells34.  
In most control cells, the firing frequency was 
relatively low while in treated cells this frequency 
was increased. The peak of the SAPs in the control 
cells was reached rapidly and had low amplitudes. In 
contrast, in the cells treated, SAPs significantly faster 
and larger characterized the electrical activity. These 
data indicate that RIN-m5F cells exhibit SAPs, and 
provide what is to our knowledge, the first evidence 
that the chronic treatment with Ghrelin or Leptin 
affects the properties of the APs in insulin-secreting 
cells, changing resting membrane potential to more 
negative values (Table 2).  
In most excitable cells, the depolarizing phase of 
the action potential reflects activation of both voltage-
gated Ca2+ channels and Na+ channels, although the 
relative contribution of the Na+ current varies between 
species and its contribution to control of insulin 
production has been previously documented1. 
Therefore, we investigated whether there were 
differences in the ionic conductances after the Leptin 
and Ghrelin treatments that could explain the changes 
in the SAP firing patterns in the RIN-m5F cells. The 
inward current was activated at membrane potentials 
(Vm) >−40 mV, while the outward component 
became evident at Vm >−10 mV. Based on the 
recording conditions and the kinetic analysis, it was 
inferred that the inward current corresponded to the 
activity of NaV and CaV channels, while the outward 
current corresponded to the activation of KV channels. 
Previous reports in mouse β-cells within intact 
pancreatic islets have shown TTX-sensitive voltage-
gated Na+ currents detectable at depolarizations  
above −50 mV, similar to values found in the present 
report. The maximum Na+ current density is observed 
at -10 mV with a peak amplitude of 120 pA/pF35. Our 
data show that in RIN-m5F under control conditions 
has less Na+ current density (15 pA/pF) at −10 mV 
than mouse β-cells, showing deference between 
species and the treatment with Ghrelin and Leptin 
hormones increase the Na+ current density. 
The chronic treatment of the RIN-m5F cells 
increased the amplitude of the inward currents and 
apparent effects on the outward current, in 
comparison with the controls. These results suggested 
that the hormone treatment may produce an increase 
in the functional expression of NaV, CaV and probably 
Kv channels and might represent a plausible 
mechanism by which the hormones may alter SAPs 
firing. Although it has been shown that the effects of 
the acute treatment with Ghrelin on insulin release 
depend on [Ca2+]i transient elevations with the 
participation of the L-type channels36, to our 
knowledge, the increase in the functional expression 
of NaV and CaV channels in response to the chronic 
treatment has not been reported previously. 
Leptin and Ghrelin increased the frequency of 
SAPs firing in the RIN-m5F cells, an effect that is 
related to an increase in the density of the inward 




macroscopic currents, we next investigated whether 
the functional expression of NaV channels was 
affected by the hormone treatment. After chronic 
treatment with Leptin or Ghrelin, the maximum Na+ 
current (INa) amplitude increased; in this same line of 
research, we investigated whether the effect of the 
Leptin and Ghrelin involved changes in the voltage 
dependence of the macroscopic INa. The results of this 
analysis showed that the position of the curves in the 
voltage axis was similar, suggesting that the 
activation of the channels was not altered by the 
hormone treatment. In mouse β-cells have been 
reported that the voltage dependence of activation is 
sigmoidal with a half-maximum at −20 mV37, 
morphology and values similar to reported in this 
report. In the same way, it is worth recalling that 
alterations in Gmax in the absence of changes in the 
voltage dependence or kinetics of the macroscopic 
currents are likely related to differences in the number 
of channels at the plasma membrane. Therefore, these 
results suggest a role for both hormones in the 
expression of NaV channels at the cell surface of the 
RIN-m5F cells. The steady-state inactivation curves 
for INa provided support for this notion. Molecular 
mechanisms and cellular signaling pathways must be 
studied to determine how these hormones promote the 
upregulation Nav and Cav.  
An increase in [Ca2+]i is essential to trigger insulin 
release38. Cav is the primary conduit for extracellular 
Ca2+ entry. Their opening plays a critical role in the 
upstroke of the β-cell action potential and their 
blockade leads to inhibition of SAPs firing and insulin 
secretion39. For all this, a series of experiments were 
then conducted to analyze and compare the CaV 
channel functional expression in the control condition 
and after chronic incubation with Leptin or Ghrelin. 
These experiments were performed using a NaV 
channel blocker (TTX 1 µM, Table 1) and Ba2+ as a 
charge carrier. The analysis of the waveform and the 
I-V plots suggested the presence of two subtypes of 
channels (LVA and HVA) in the cell membrane of the 
RIN-m5F cells. Interestingly, the peak current 
amplitudes in the cells treated with Ghrelin were 
greater than in those of the control cells at almost all 
voltages explored. 
We next explored whether the treatment with 
Ghrelin could differentially affect the two 
components of IBa in the RIN-m5F cells. The 
procedure used for the separation of these current 
components was based on the fact that the LVA 
component inactivates faster than the HVA 
component30-31. Likewise, the inactivating component 
was increased in cells treated chronically with 
Ghrelin. That is, the IBa carried out by LVA Cav 
without significant changes in the non-inactivation 
component (HVA). When we corroborated the 
presence of the two components of IBa by analyzing 
tail currents. As occur in other endocrine cells, the 
slow and fast components indicate the closure of the 
LVA and HVA channels, respectively28-30,40. The 
results confirm our observation that IBa is larger in the 
RIN-m5F cells treated with the hormones in 
comparison to the controls, and Ghrelin increases the 
amplitude of peak component (Ipeak) without affecting 
the channel voltage dependence of activation. It is 
important to note that there is no evidence of low 
threshold T-type ICa in mouse β-cells and T-type 
transcripts are only expressed at very low levels41. 
Our results show the existence of a component of 
Barium current with rapid inactivation reported 
previously42. To clarify is necessary to perform 
molecular biology experiments to determine LVA 
type calcium channel present in RIN-m5F cells 
membrane and analyze signaling pathways that 
explain the effect of Ghrelin on this protein. There is 
evidence that Ca2+ channel activity is regulated by 
glucose metabolism. Thus, the glucose metabolite 
glyceraldehyde increases Ca2+ channel activity by a 
protein kinase C (PKC)-dependent mechanism in 
RIN-m5F cells43. Probably the intracellular signaling 
pathway that uses Ghrelin44.  
The chronic incubation effect with Leptin on CaV 
channel functional expression in the RIN-m5F cells, 
suggest a preferential effect of the hormone on the 
HVA channels. Consistent with this, the density of the 
sustained IBa component was increased in the  
Leptin-exposed cells. Similar effects are reported in 
other cells30.  
There are different types of HVA calcium channels 
β-cells, they can be identified by their biophysical 
properties and the effects of selective inhibitors.  
L-type channels make the dominant contribution to 
the Ca2+ current of mouse β-cells (50%)1. The 
presence of isradipine-sensitive L-type calcium 
channels in RIN-m5F cells has been reported45. 
Although other HVA calcium channels have been 
reported in RIN-m5F cells, L-type channels are 
primarily involved in insulin secretion5-7,42. Many are 
the intracellular signaling pathways that leptin uses to 
promote its effect in the tissues25,46, exploring which 




could be activated in pancreatic β-cells RIN-m5F is 
necessary to elucidate this point.  
Respect to the time course of IBa stimulation by 
Leptin, as well as by Ghrelin, these data confirm that 
Leptin and Ghrelin regulate IBa density when 
chronically applied to RIN-m5F cells. 
Last, the release of insulin from RIN-m5F cells 
kept in culture under control conditions and in the 
presence of the hormones to evaluate the functional 
repercussion of the treatment with Leptin and  
Ghrelin on the membrane currents and the  
electrical activity, showed different results between 
Ghrelin and Leptin. These findings suggest that 
Leptin, by altering both types of CaV channels, LVA 
and HVA, produces a stimulating effect on insulin 
secretion, in contrast to what is observed with  
Ghrelin that only increase the functional expression  
of the LVA channels. These data differ from previous 
findings indicating that Ghrelin increases [Ca2+]i in  
β-pancreatic cells and thereby promotes insulin 
secretion47, and with the idea that LVA channels may 
play a relevant role in the basal and glucose-
stimulated insulin secretion1,5-7,48. It should also be 
mentioned that T-type channels not only contribute to 
the secretion of insulin but participate in determining 
the fluctuations in the membrane resting potential of 
endocrine cells that activate NaV channels and 
generate APs25,49-51.  
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